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The development of the male reproductive
system is androgen-dependent and is there-
fore vulnerable to antiandrogens. Among the
chemicals humans are routinely exposed to
are phthalate esters, several of which have
antiandrogenic properties. Phthalate esters
are used most commonly as plasticizers.
They constitute 10–60% by weight of many
plastics because they impart ﬂexibility, trans-
parency, and other desirable physical proper-
ties. Because phthalate esters are not
covalently bound to the polymers with
which they are mixed, they can leach into
the foods, beverages, or other materials con-
tained by these plastics. Consequently,
because plastics are so commonplace, phtha-
late esters are ubiquitous in foods and the
environment (1,2).
Many phthalate esters have long been
known to be reproductive toxicants when
animals are dosed as juveniles or adults, and
their teratogenicity is well established (1,3), yet
little has been published on the effects of in
utero and lactational (or continuous multigen-
erational) exposure to any phthalate ester on
postnatal development of the male or female
reproductive systems or sexual differentiation
of the central nervous system (CNS).
Of the approximately 20 phthalate esters
in common use, di(2-ethylhexyl) phthalate
(DEHP) constitutes approximately half the
total; 1–4 million tons are produced per year
(1,2). DEHP is used in numerous consumer
products, especially those made of flexible
polyvinyl chloride. The use of DEHP in
teething rings, paciﬁers, and toys for young
children has largely been discontinued, but
DEHP continues to be used in clothing,
toys, food containers, and a variety of build-
ing, household, and automotive products
(3,4). Typical human exposure is estimated
to be 4–30 µg DEHP/kg/day, but some
individuals have substantially greater expo-
sure resulting from DEHP-plasticized med-
ical devices such as blood bags, hemodialysis
tubing and membranes, autophoresis equip-
ment, and nasogastric feeding tubes (5). The
average long-term dialysis patient is reported
to receive approximately 12 g of DEHP over
the course of a year (6).
The impetus for our investigations of
effects of DEHP was provided by a report
that in utero and lactational di(n-butyl)
phthalate exposure disrupts male reproductive
system development by what appears to be an
antiandrogenic mechanism (7). Because
DEHP was already known to have antiandro-
genic properties, we hypothesized that in
utero and lactational DEHP exposure would
cause similar responses. Effects of DEHP on
juvenile or adult rodents include reductions in
testis (8–11) and epididymis (12) weights,
severe reductions in sperm production
(12,13), and various pathological effects on
the testis (8,10,11,14–17). Accessory sex
organs are highly androgen-dependent, and
reductions in seminal vesicle (10,11,18) and
ventral prostate (10,11,18) weights have com-
monly been observed in DEHP-treated rats.
Reductions in serum testosterone concentra-
tions have also been seen (9,10). In all these
studies, males were not exposed until after
weaning, when the male reproductive system
is far less vulnerable to many toxicants than
before weaning, and doses were typically
1,000–2,000 mg DEHP/kg/day. In other
studies, in utero DEHP exposure (alone) and
lactational DEHP exposure (alone) each
reduced testis weight and epididymal sperm
counts in rats (19–21).
The primary information gap when we
began this research was that there was not a
single publication on the effects of in utero
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Several members of the phthalate ester family have antiandrogenic properties, yet little is known
about how exposure to these ubiquitous environmental contaminants early in development may
affect sexual development. We conducted experiments to determine effects of in utero and lacta-
tional exposure to the most prevalent phthalate ester, di(2-ethylhexyl) phthalate (DEHP), on
male reproductive system development and sexual behavior. Sprague-Dawley rats were dosed with
corn oil or DEHP (0, 375, 750, or 1,500 mg/kg/day, per os) from gestation day 3 through post-
natal day (PND) 21. Dose-related effects on male offspring included reduced anogenital distance,
areola and nipple retention, undescended testes, and permanently incomplete preputial separa-
tion. Testis, epididymis, glans penis, ventral prostate, dorsolateral prostate, anterior prostate, and
seminal vesicle weights were reduced at PND 21, 63, and/or 105–112. Additional dose-related
effects included a high incidence of anterior prostate agenesis, a lower incidence of partial or com-
plete ventral prostate agenesis, occasional dorsolateral prostate and seminal vesicle agenesis,
reduced sperm counts, and testicular, epididymal, and penile malformations. Many DEHP-
exposed males were sexually inactive in the presence of receptive control females, but sexual inac-
tivity did not correlate with abnormal male reproductive organs. These results suggest that in
utero and lactational DEHP exposure also inhibited sexually dimorphic central nervous system
development. No major abnormalities were found in any of eight control litters, but DEHP
caused severe male reproductive system toxicity in ﬁve of eight litters at 375 mg/kg/day, seven of
eight litters at 750 mg/kg/day, and ﬁve of ﬁve litters at 1,500 mg/kg/day. These results demon-
strate that the male reproductive system is far more sensitive to DEHP early in development than
when animals are exposed as juveniles or adults. The effects of DEHP on male reproductive
organs and sexual behaviors and the lack of signiﬁcant effects on time to vaginal opening and ﬁrst
estrus in their littermates demonstrate that DEHP (and/or its metabolites) affects development of
the male reproductive system primarily by acting as an antiandrogen. The pattern of effects of in
utero and lactational DEHP exposure differed from patterns caused by other phthalate esters, and
the preponderance of anterior prostate agenesis appears to be unique among all chemicals. These
results suggest that DEHP acts partly by mechanisms distinct from those of other antiandrogens.
Key words: antiandrogens, di(2-ethylhexyl) phthalate, in utero exposure, lactational exposure,
male reproductive system development, masculine sexual behaviors, reproductive organ agenesis.
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tional DEHP exposure on any aspect of post-
natal development of the male (or female)
reproductive system or sexual differentiation
of the CNS in any species, except for a report
that fertility was not impaired in male or
female rats (22). We therefore conducted a
dose–response, time course experiment to
test the hypothesis that male reproductive
system development and sexually dimorphic
CNS development in rats are vulnerable to
in utero and lactational DEHP exposure.
While this work was in progress, Arcadi et al.
(23) reported that low-level in utero and lac-
tational DEHP exposure reduces testis
weight and alters testicular morphology in
rats. And after completing the in-life portion
of this research, Gray et al. (24) published
results of a study in which effects of a single
daily maternal dose of DEHP on male repro-
ductive system development in rats were
determined.
Methods
Pregnant Sprague-Dawley rats were received
from Harlan Sprague Dawley (Madison, WI)
on gestation day (GD) 1, the day after they
were found to be sperm-positive following
overnight mating. Rats were housed individ-
ually in suspended plastic cages with heat-
treated, chipped aspen bedding and had ad
libitum access to feed (5012 Rat Diet; PMI
Nutrition International, Brentwood, MO)
and water. Rooms were kept at 20–21°C;
humidity was typically 35–50%; and lights
were on from 0600 to 1800 hr. We ran-
domly assigned rats to treatment groups (and
randomly reassigned them if necessary) to
attain comparable mean body weights in
each group. Each dam was dosed orally with
tocopherol-stripped corn oil or DEHP (375,
750, 1,500, or 3,000 mg/kg/day) from GD 3
through postnatal day (PND) 21 based on its
body weight that day. Corn oil was obtained
from ICN Biomedicals (Aurora, OH), and
DEHP (99% pure) was purchased from
Aldrich (Milwaukee, WI). Rats given 0, 375,
or 750 mg/kg/day received 1.53 mL/kg/day
corn oil ± DEHP, the volume given to rats
dosed with pure DEHP at 1,500 mg/kg/day.
Doses were chosen on the basis of those used
previously to examine effects of DEHP on
the male reproductive system of rats treated
as juveniles or adults. All animal procedures
were conducted under protocols approved by
the University of Wisconsin Research Animal
Resources Center.
We conducted the experiment in two
blocks, both of which included all treatment
groups. Because of excessive toxicity, how-
ever, the 3,000 mg DEHP/kg/day dose was
not used in the second block. Litters totaled
eight each at 0, 375, and 750 mg/kg/day and
ﬁve at 1,500 mg/kg/day.
To determine the number of pups born
to each dam as accurately as possible, we
examined cages at frequent intervals during
parturition. Dead pups were removed when
found and sexed when possible. Pups were
toe-clipped so records could be kept on each
individual. Litters were normalized to 10
pups each 1–2 days after birth and main-
tained at 10 by replacing pups that died.
When pups had to be added to a litter, they
were taken from litters exposed to the same
or lower dose of DEHP. Litter independence
was maintained because data from pups
added to litters are not reported.
We weighed pups on PND 1 (the day
after birth), PND 7, and weekly thereafter.
We measured anogenital distance using
Vernier calipers on PND 1, and we counted
areolas (with and without nipple buds) daily
beginning on PND 11 and continuing until
hair obscured them. These measurements
were made on all pups. On PND 21, we
removed pups from their mothers and
housed them by litter and sex. Dams were
necropsied on PND 21–22 and the number
of implantation sites was recorded.
Time to vaginal opening was determined
by daily inspection of all females starting on
PND 24, and time to ﬁrst estrus was deter-
mined by vaginal lavage of two randomly
selected females per litter beginning the day
of vaginal opening. Time to preputial separa-
tion was determined by daily inspection of all
males beginning on PND 38. We continued
observations until preputial separation was
complete or until PND 63, whichever came
ﬁrst, with a ﬁnal observation at necropsy.
One male per litter was necropsied
(when available) on PND 21, 63, and 105;
remaining males were necropsied on PND
112. Rats were killed by CO2 overdose. We
recorded testicular position after opening the
abdominal cavity. The glans penis, one epi-
didymis, and one testis from rats 63 days of
age and older were ﬁxed in neutral-buffered
formalin; results will be presented elsewhere.
The other testis and epididymis were frozen
on dry ice for analysis of daily sperm produc-
tion and cauda epididymal sperm numbers
(25). When testis sizes differed noticeably,
the smaller testis and corresponding epi-
didymis were fixed and the larger one was
frozen. Accessory sex organs were removed
on PND 21 under a dissecting microscope
by personnel who routinely dissect these
organs from neonatal mice. We weighed
accessory sex organs without expressing
ﬂuid. We counted nipples after shaving the
chest and abdomen.
We examined masculine sexual behaviors
in males scheduled for necropsy on PND
105. These animals were placed on a
reversed light/dark cycle at least 14 days
before the test. Each male was allowed to
gain sexual experience by spending 30 min
with a sexually receptive female followed by
30 min with another, 5–8 days before the
test. The females were ovariectomized con-
trol adult Sprague-Dawley rats in which sex-
ual receptivity had been induced by
subcutaneous injection of 120 µg/kg estra-
diol benzoate (Sigma Chemical Co., St.
Louis, MO) and 5 mg/kg progesterone
(Sigma), 48 and 6 hr, respectively, before
testing. Steroids were dissolved in corn oil,
and these females were also on a reversed
light/dark cycle. We conducted tests at least
2 hr into the dark cycle under dim red light
on about PND 77. Males were allowed 5
min to habituate to a 60 × 30 × 30 cm glass
observation cage with wood shavings before
the female was introduced. We recorded or
calculated the following male behaviors:
number of mounts, number of intromis-
sions, latency to mount, latency to intromis-
sion, latency to ejaculation, postejaculatory
interval, copulatory rate, and copulatory efﬁ-
ciency (26,27). Males were observed for one
complete ejaculatory series and the subse-
quent postejaculatory interval, although
observations were discontinued if ejaculation
did not occur within 45 min. Females dis-
played a high degree of sexual receptivity
throughout the observations or were
replaced by ones that did. All sessions were
videotaped for later analysis. Tests were con-
ducted by a person who did not know which
treatment group any of the males were from.
We conducted statistical analysis with the
litter as the experimental unit. We conducted
parametric analyses on untransformed data
and on log, square-root, and inverse trans-
forms as well as on ranked data. For data that
passed Levene’s test for homogeneity of vari-
ance and which appeared to be normally dis-
tributed, we performed analysis of variance
(ANOVA). If a signiﬁcant effect was found,
we used the least signiﬁcant difference test to
determine which group(s) differed from con-
trol. We also analyzed data by the Kruskal-
Wallis nonparametric ANOVA and by the
median test. We used the distribution-free
multiple comparison test as the post hoc test
for nonparametric analyses. We analyzed
body weight data by repeated-measures
ANOVA. Incidence data were analyzed by
the row × column chi square test, followed by
Fisher’s Exact test. Signiﬁcance was set at (p <
0.05). Results are presented as means ± SE.
Results
Dose. The first block of the experiment
included six sperm-positive females given
3,000 mg DEHP/kg/day. Two had no
implantation sites, two were pregnant but
miscarried, one gave birth to nine pups that
died within hours, and one gave birth to
seven pups. Only two of these pups lived
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ductive system abnormalities (both were
males). Consequently, we discontinued the
3,000 mg DEHP/kg/day dose. All results
described below are from animals dosed with
or exposed to 0, 375, 750, or 1,500 mg
DEHP/kg/day.
Effects on dams and litter size. DEHP
had no statistically significant effect during
pregnancy on the body weight of rats found
to have delivered pups (data not shown).
However, maternal weight gain subsequent
to the start of dosing on GD 3 was signifi-
cantly reduced on GD 16–20 by the middle
and high doses. Weight gain between GD 3
and GD 20 is shown in Table 1. In contrast,
DEHP had no signiﬁcant effect on maternal
body weight (data not shown) or weight gain
(Table 1) between birth and weaning.
Additional reproductive parameters are
shown in Table 1. The mean number of
implantation sites per dam appeared to be
slightly decreased by DEHP, but this effect
was not statistically signiﬁcant. All rats with
implantation sites gave birth to live pups,
except one given the middle dose and two
given the high dose. The number of pups
born per dam was signiﬁcantly reduced only
at the high dose. (One dam given the high
dose had no implantation sites but is not
included in these calculations because she
may not have been pregnant when dosing
began.) DEHP appeared to cause dose-
related increases in postnatal mortality at the
middle and high doses, although effects were
not statistically significant when calculated
either as postnatal deaths per litter (data not
shown) or as percent survival after birth.
Nearly all pup deaths occurred within 2 days
of birth. The net result of the prenatal and
postnatal losses described above is that the
number of pups per dam that survived until
weaning was significantly reduced at the
middle and high doses.
Effects on pup development. In utero and
lactational DEHP exposure caused dose-
related reductions in body weight. In males
exposed to 750 mg/kg/day, the decrease was
statistically signiﬁcant from PND 63 through
PND 105 and averaged 6% throughout this
time, whereas in males exposed to the high
dose the decrease averaged 12% and was sta-
tistically signiﬁcant throughout development.
Body weights of female offspring tended to
be reduced (by an average of 8% at the high
dose), but differences were not statistically
signiﬁcant.
Effects of in utero and lactational DEHP
exposure on indices of sexual development are
presented in Figure 1. Anogenital distance is
androgen-dependent and was 54% shorter
in control females on PND 1 than in control
males (Figure 1A). DEHP exposure caused a
dose-related reduction in anogenital distance
in males that was statistically significant at
the middle and high doses. When normal-
ized to the cube root of body weight [to
account for differences in body size (28)],
anogenital distance in males was still signiﬁ-
cantly reduced at the middle and high doses
(data not shown). In contrast to effects on
males, in utero and lactational DEHP expo-
sure had no significant effect on anogenital
distance in females regardless of whether
results were expressed as absolute distance
(Figure 1A) or divided by the cube root of
body weight (data not shown).
Nipples and/or areolas were present in
many DEHP-exposed males, whereas control
males had none and females had 12. On
PND 14, litter averages for the number of
areolas per male were signiﬁcantly increased
at the middle and high doses and averaged
9.7 at the high dose (Figure 1B). The inci-
dence of litters in which one or more males
had areolas on PND 14 was statistically sig-
niﬁcant at all 3 doses (Figure 1C). The num-
ber of detectable nipples in adulthood (data
not shown) was lower than the number of
areolas on PND 14; nevertheless, nipples
were found in some males from the low-dose
group, most males from the middle dose
group, and all males from the high-dose
group when necropsies were conducted on
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Table 1. Reproductive parameters in rats dosed with DEHP from GD 3 through PND 21.
Maternal DEHP dose (mg/kg/day)
Parameter 0 375 750 1,500
Prenatal weight gain (g) 128 ± 4 (8) 123 ± 7 (8) 99 ± 10 (8)* 87 ± 13 (6)*
Postnatal weight gain (g) 17 ± 3 (8) 24 ± 4 (8) 20 ± 3 (8) 15 ± 4 (5)
Implantation sites per dam 13.5 ± 0.9 (8) 12.1 ± 0.6 (8) 12.2 ± 0.7 (9) 10.5 ± 1.1 (8)
Incidence of parturition 100% (8) 100% (8) 89% (9) 75% (8)
Pups born per dam 12.5 ± 1.0 (8) 11.4 ± 0.8 (8) 9.6 ± 1.3 (8) 7.7 ± 1.4 (6)*
Postnatal pup survival 87 ± 5% (8) 86 ± 4% (8) 74 ± 7% (8) 59 ± 15% (6)
Pups per dam that survived 10.9 ± 1.0 (8) 9.8 ± 0.8 (8) 7.5 ± 1.3 (8)* 5.0 ± 1.3 (6)*
Numbers shown are means ± SE or incidences per dam or litter in each treatment group. The number of replicates (dams
or litters) is shown in parentheses. Prenatal weight gain is from GD 3 to GD 20 for dams that delivered one or more living
pups, whereas postnatal weight gain is from PND 1 to PND 21 for dams that maintained litters throughout this time. Pups
born per dam are for dams known to have given birth to one or more living pups. 
*Signiﬁcantly different from control at p < 0.05.
Figure 1. Effects of in utero and lactational DEHP exposure on sexual development. Dams were orally
dosed with DEHP or vehicle from GD 3 through PND 21. (A) Anogenital distance on PND 1. (B) Areolas per
male on PND 14. (C) Incidence of litters in which males had areolas on PND 14 or nipples in adulthood. (D)
Incidence of litters with incomplete preputial separation. Numbers shown are means ± SE of litter aver-
ages or are incidences among litters in each treatment group. The number of replicates (litters) was 8 at 0
and 375 mg/kg/day, 7–8 at 750 mg/kg/day, and 5 at 1,500 mg/kg/day. 
*Signiﬁcantly different from control at p < 0.05.
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* *PND 63, 105, and 112. Nipple retention per
litter in adulthood (Figure 1C) was statisti-
cally signiﬁcant at all DEHP doses tested.
Preputial separation, an androgen-depen-
dent index of pubertal development, was
complete in all 34 control males (from 8 lit-
ters) at an average of 43 days of age and 196
g body weight. Two of 26 males exposed to
the low dose, 3 of 21 males at the middle
dose, and 5 of 7 males at the high dose never
completed preputial separation. In these rats,
the prepuce remained attached to the dorsal
surface of the glans penis. In most cases, the
penis was otherwise normal in appearance.
The incidence of incomplete preputial sepa-
ration per litter (Figure 1D) was statistically
signiﬁcant only at the high dose but is con-
sidered biologically significant at all three
doses because this phenomenon is rare in
control rats. Among males that completed
preputial separation, in utero and lactational
DEHP exposure slightly but nonsigniﬁcantly
increased time to separation (data not shown)
and had little if any effect on body weight at
separation (data not shown).
Effects on male sex organs. After wean-
ing, testes from control rats could readily be
detected in the scrotum by palpation, but
one or both testes could not be detected in
many DEHP-exposed rats. Because some of
these testes were very small, assessment of
testis descent in live animals was considered
less reliable than observations made after rats
were killed by CO2 overdose. Many testes
from DEHP-exposed rats were in the
abdominal cavity at necropsy, often on the
contralateral side, whereas all testes from
control rats were in the scrotum (Figure 2).
Undescended testes were observed at all
three doses on PND 21, although the num-
ber per rat was signiﬁcantly increased only at
the highest dose (Figure 2A). However, the
incidence of litters with an undescended
testis was significantly increased at the 2
highest doses (Figure 2B). In adulthood, the
average number of undescended testes per
rat was far smaller at each dose than on
PND 21 (Figure 2A). Nevertheless, litters in
which one or more males had an unde-
scended testis in adulthood were found at
each DEHP dose (Figure 2B). These results
indicate that in utero and lactational DEHP
exposure both delays and permanently pre-
vents testis descent. Undescended testes
tended to be far smaller than descended
testes, but small testes were found in both
the descended and undescended positions.
On PND 21, most undescended testes were
similar in size to their descended partners,
but in adulthood only one DEHP-exposed
rat (at 750 mg/kg/day) had an undescended
testis that was normal size.
Effects of in utero and lactational DEHP
exposure on testis, epididymis, and glans
penis weights are shown in Table 2. Testis
weights were reduced to roughly 50% of
control values at the high dose at all times
examined. On PND 21 the reduction was
significant at the 2 highest doses, and
testis/body weight ratios were significantly
reduced at all 3. On PND 63 both absolute
and relative testis weights were signiﬁcantly
reduced at the 2 highest doses. Testis weight
data at PND 105 could not be analyzed by
parametric statistical procedures because of
heterogeneity of variance; reductions in
absolute and relative testis weights at this
time were not statistically signiﬁcant.
Epididymis weights were significantly
reduced by in utero and lactational DEHP
exposure at the middle and high doses on
PND 63, as were epididymis/body weight
ratios. Similar reductions in epididymis
weight were seen at PND 105, although the
effect was statistically signiﬁcant only at the
middle dose. Visually obvious epididymal
abnormalities were seen in one rat at the low
dose, ﬁve rats (from two litters) at the mid-
dle dose, and two rats (from two litters) at
the high dose. The most common finding
was agenesis of the caput epididymis, though
partial or complete absence of the corpus
epididymis and a case of epididymal edema
were also observed.
Dose-related reductions in glans penis
weight were statistically significant at the
middle and high doses on PND 21, 63, and
105; however, relative glans penis weight was
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Figure 2. Effects of in utero and lactational DEHP exposure on testis descent. Dams were orally dosed
with DEHP or vehicle from GD 3 through PND 21. (A) Number of undescended testes per rat on PND 21
and in adulthood. (B) Incidence of litters with undescended testes on PND 21 and in adulthood. Numbers
shown are means ± SE or are incidences among litters in each treatment group. The number of replicates
(litters) was 8 at 0 mg/kg/day, 7–8 at 375 and 750 mg/kg/day, and 5 at 1,500 mg/kg/day. Results from PND
21 are from one rat per litter necropsied at this time, whereas results from adulthood are litter averages
from all rats necropsied as adults. 
*Signiﬁcantly different from control at p < 0.05.
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Table 2. Effects of in utero and lactational DEHP exposure on sex organ weights.
Maternal DEHP dose (mg/kg/day)
Organ/age (days) 0 375 750 1,500
Testes weight (mg)
21 247 ± 13 (8)a 222 ± 17 (7) 192 ± 15 (8)* 153 ± 9 (5)*
(0.509 ± 0.017)b (0.451 ± 0.018)* (0.435 ± 0.017)* (0.398 ± 0.028)*
63 3,500 ± 65 (8) 3,596 ± 80 (8) 2,571 ± 255 (7)* 2,048 ± 107 (5)*
(1.082 ± 0.020) (1.095 ± 0.020) (0.821 ± 0.081)* (0.696 ± 0.029)*
105 3,718 ± 85 (8) 3,689 ± 136 (7) 2,624 ± 467 (7) 1,467 ± 63 (2)
(0.886 ± 0.018) (0.908 ± 0.040) (0.645 ± 0.109) (0.390 ± 0.013)
Epididymides weight (mg)
21 ND ND ND ND
63 624 ± 18 (8) 613 ± 25 (8) 412 ± 62 (7)* 429 ± 42 (5)*
(0.193 ± 0.005) (0.186 ± 0.006) (0.132 ± 0.020)* (0.148 ± 0.018)*
105 1,053 ± 25 (8) 957 ± 52 (7) 640 ± 136 (7)* 581 ± 50 (2)
(0.251 ± 0.005) (0.236 ± 0.014) (0.158 ± 0.032)* (0.155 ± 0.015%)*
Glans penis weight (mg)
21 27.7 ± 1.2 (8) 24.8 ± 1.3 (7) 22.7 ± 1.1 (8)* 19.6 ± 0.4 (5)*
(0.0575 ± 0.0026) (0.0510 ± 0.0022) (0.0534 ± 0.0049) (0.0513 ± 0.0037)
63 91.1 ± 1.7 (8) 88.2 ± 1.8 (8) 80.7 ± 2.3 (7)* 75.7 ± 2.7 (3)*
(0.0281 ± 0.0005) (0.0269 ± 0.0004) (0.0259 ± 0.0011) (0.0269 ± 0.0009)
105 102.5 ± 1.5 (8) 99.1 ± 1.8 (7) 88.5 ± 3.7 (7)* 81.1 ± 3.2 (2)*
(0.0244 ± 0.0003) (0.0245 ± 0.0010) (0.0220 ± 0.0010)* (0.0215 ± 0.0006)
ND, not determined. Dams were orally dosed with DEHP or vehicle from GD 3 through PND 21. One male per litter was
necropsied at each designated time. 
aNumbers shown are means ± SE, with the number of replicates (litters) in parentheses. bValues shown are organ
weight:body weight ratio. *Signiﬁcantly different from control at p < 0.05.signiﬁcantly reduced only on PND 105 and
only by the middle dose. The penis appeared
to be structurally abnormal in several DEHP-
exposed rats, but deﬁnitive assessments could
not be made at necropsy (other than incom-
plete preputial separation), and results of his-
tological evaluation were inconclusive.
Daily sperm production appeared to be
inhibited in a dose-related manner on PND
63 by in utero and lactational DEHP expo-
sure, both per testis (Table 3) and per gram
testis (data not shown), but neither effect was
statistically signiﬁcant. The number of cauda
epididymal sperm was signiﬁcantly reduced at
the 2 highest doses (Table 3). These decreases
in testicular spermatid and epididymal sperm
numbers represent minimum effects of
DEHP, because when testis and epididymis
sizes differed, the smaller ones were placed in
ﬁxative and only the larger ones were frozen
for spermatid and sperm counts.
Effects of in utero and lactational DEHP
exposure on accessory sex organ weights are
shown in Figure 3. Ventral prostate weights
were signiﬁcantly reduced by the middle and
high doses of DEHP on PND 21 and by the
middle dose on PND 105. These effects
were also significant when ventral prostate
weight was expressed relative to body
weight. Ventral prostate weight was also
decreased, though not signiﬁcantly, on PND
63. Reductions in ventral prostate weight
were greatest at PND 21, when a 60%
decrease was seen at the high dose.
On PND 21, dorsolateral prostate
weights were signiﬁcantly reduced by 80% at
the high dose and to a lesser extent at the
middle dose. The magnitude of these effects
decreased with age, but signiﬁcant reductions
were still seen at the high dose on PND 63
and at the two highest doses on PND 105.
The reduction in dorsolateral prostate weight
on PND 63 was not statistically significant
when calculated relative to body weight, but
dorsolateral prostate/body weight ratios were
signiﬁcantly reduced at the middle and high
doses at the other two times.
Weights of the anterior prostate were
greatly reduced at all times examined: On
PND 63 a 75% decrease was observed at the
high dose. The reductions were statistically
signiﬁcant at the two highest doses on PND
21 and at all three doses on PND 63 and
PND 105. Identical statistical results were
obtained when relative anterior prostate
weights were calculated.
Dose-related reductions in seminal vesi-
cle weights were observed on PND 21, when
weights at the high dose were reduced by
62%. Reductions at the middle and high
doses were statistically significant at this
time, as were seminal vesicle/body weight
ratios at all three doses. Apparent decreases
in seminal vesicle weight on PND 63 and
PND 105 were not statistically signiﬁcant.
In utero and lactational DEHP exposure
caused agenesis of one or more accessory sex
organs in many litters (Table 4). Ventral
prostate agenesis (one lobe or both) was dose
related and was seen at all 3 doses, whereas
dorsolateral prostate agenesis was observed in
only one low-dose and one high-dose litter.
The most predominant effect of DEHP was
anterior prostate agenesis: One or both lobes
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Table 3. Effects of in utero and lactational DEHP exposure on PND 63 sperm counts.
Maternal DEHP dose (mg/kg/day)
0 375 750 1,500
Daily sperm production (106 per testis) 34.2 ± 1.5 36.5 ± 1.2 25.6 ± 4.5 24.4 ± 5.4
(8) (8) (7) (5)
Epididymal sperm number (106 per cauda) 55.5 ± 3.7 46.5 ± 5.1 29.8 ± 8.7* 19.3 ± 7.5*
(8) (7) (7) (5)
Dams were orally dosed with DEHP or vehicle from GD 3 through PND 21. One male per litter was necropsied on PND 63.
Numbers shown are means ± SE, with the number of replicates (litters) in parentheses. 
*Signiﬁcantly different from control at p < 0.05.
Figure 3. Effects of in utero and lactational DEHP exposure on absolute and relative accessory sex organ weights. Top row, PND 21; middle row, PND 63; bottom
row, PND 105. Dams were orally dosed with DEHP or vehicle from GD 3 through PND 21. One male per litter was necropsied at each designated time. Numbers
shown are means ± SE. The number of replicates (litters) was generally 7–8 at 0, 375, and 750 mg/kg/day, whereas at 1,500 mg/kg/day there were 5 replicates on
PND 21 and 63 and 2 on PND 105. 
*Both absolute and relative organ weights were signiﬁcantly different from control at p < 0.05. #Absolute organ weight was signiﬁcantly different from control at p < 0.05.
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Absolutewere missing from one of eight low-dose lit-
ters, five of eight middle dose litters, and
four of five high-dose litters. In contrast,
seminal vesicle agenesis was seen only at the
high dose (two litters). No such abnormali-
ties were seen in any male from any of the
eight control litters. Statistical analysis
revealed that the only significant effect was
anterior prostate agenesis at the middle and
high doses; however, the rarity of ventral,
dorsolateral, and anterior prostate agenesis in
control rats suggests that the absence of these
organs at the lowest dose of DEHP was bio-
logically signiﬁcant. Table 4 also shows the
incidence of accessory sex organ agenesis
among all pups.
Effects on male sexual behaviors. We
examined effects on masculine sexual behav-
iors by allowing one male per litter to mate
with a receptive control female. Males were
about 77 days of age when tested. Seven of
eight control males displayed typical sexual
behaviors and ejaculated within the 45-min
observation period (ejaculatory latencies aver-
aged 14 min). In contrast, three of seven low-
dose males never mounted, intromitted, or
ejaculated; all seven males at the middle dose
mounted (although two had extraordinarily
long mount latencies), but three never intro-
mitted and four did not ejaculate; and neither
rat at the high dose mounted, intromitted, or
ejaculated. Due to the small number of ani-
mals tested, the only statistically significant
effect when exposure groups were analyzed
separately was a reduction in the incidence of
mounting at the high dose. However, when
results from the 2 highest DEHP exposure
groups were combined, the reduction in the
incidence of ejaculation was statistically signif-
icant, and when results from all 16 DEHP-
exposed rats were combined, the p-value for
this effect was 0.0507. No obvious differences
appeared between the behaviors of DEHP-
exposed rats that were sexually active and
those of the sexually active control rats.
Effects on F1 females. Several observa-
tions were made on female offspring besides
those described above for body weight and
anogenital distance. As shown in Table 5,
time to vaginal opening appeared to be
reduced (which suggests that DEHP is estro-
genic), but time to ﬁrst estrus appeared to be
slightly increased (which suggests that it is
not). Neither effect was statistically signifi-
cant. Body weights at these times were not
affected by DEHP, except for a significant
reduction at vaginal opening caused by the
high dose of DEHP.
Discussion
DEHP causes abnormal sexual development
by acting primarily as an antiandrogen.
Results of these experiments demonstrate
that in utero and lactational DEHP exposure
can profoundly alter male reproductive sys-
tem development (including sexual behav-
iors) in rats. These ﬁndings conﬁrm many of
the observations made by Gray et al. (24)
and extend others. Four effects seen in both
laboratories (reductions in testis, epididymis,
ventral prostate, and seminal vesicle weights)
had already been reported in animals given
DEHP as juveniles or adults (8–12,18), but
others (ventral prostate, seminal vesicle, and
caput epididymis agenesis; reductions in
anogenital distance; areola and nipple reten-
tion; reductions in glans penis weight; and
penile abnormalities) had not been reported
previously. We also observed effects of
DEHP not reported by Gray et al. (24) or
others: dorsolateral and anterior prostate
agenesis and weight reductions, undescended
testes, permanently incomplete preputial
separation, and demasculinized sexual
behaviors. Several differences between our
observations and those of Gray et al. (24)
presumably stem from the fact that we
examined additional end points, whereas
others may stem from the longer dosing
period we used. Gray et al. (24) observed
high incidences of vaginal pouches, hemor-
rhagic testes, and hypospadias whereas we
did not. The reason for these differences is
not known.
Nearly every effect we observed is a clas-
sic sign of antiandrogenic activity; however,
effects of antiandrogens on male reproduc-
tive system development are similar in
many ways to effects of estrogens (29). If
DEHP had affected development in males
by acting primarily as an estrogen, time to
vaginal opening and ﬁrst estrus should have
been reduced in their littermates (30).
Neither was significantly affected. And
most DEHP-exposed males had nipples,
which is generally considered to be
diagnostic for antiandrogens (31). Diethyl-
stilbestrol can also cause nipple retention in
males (32), but maternal doses orders of
magnitude higher than those that shorten
time to vaginal opening are needed to cause
this effect (33). Although DEHP has been
reported to be weakly estrogenic (34) and
to be associated with premature breast
development in humans (35), we conclude
that the effects of DEHP described in this
report are due primarily to one or more
antiandrogenic mechanisms.
Effects of in utero and lactational DEHP
exposure on masculine sexual behaviors
appear to be due to incomplete sexual differ-
entiation of the CNS. Nine of 16 DEHP-
exposed males failed to ejaculate during
sexual behavior testing, versus one of eight
control males. Eight of these nine had no
intromissions, and ﬁve failed to mount a sin-
gle time. If failure to ejaculate had been
caused by low circulating testosterone con-
centrations in adulthood, seminal vesicle
weights would have been substantially
smaller than normal. Yet seminal vesicles in
DEHP-exposed rats that failed to ejaculate
averaged 87 ± 3% of the control weight,
whereas those in rats that ejaculated averaged
81 ± 9% of control. In addition, circulating
testosterone concentrations only one-third of
normal are sufﬁcient to fully maintain mas-
culine sexual behaviors in rats (36). Clearly,
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Table 4. Incidence of sex organ agenesis in rats with in utero and lactational DEHP exposure.
Maternal DEHP dose (mg/kg/day)
Organ 0 375 750 1,500
Ventral prostate 0/8 1/8 2/8 2/5
(0/42) (1/32) (5/29) (3/12)
Dorsolateral prostate 0/8 1/8 0/8 1/5
(0/42) (1/32) (0/29) (2/12)
Anterior prostate 0/8 1/8 5/8* 4/5*
(0/42) (1/32) (9/29) (6/12)
Seminal vesicles 0/8 0/8 0/8 2/5
(0/42) (0/32) (0/29) (2/12)
Dams were orally dosed with DEHP or vehicle from GD 3 through PND 21. The ﬁrst pair of numbers show the incidence
per litter; the second, in parentheses, show the incidence among all pups. 
*Signiﬁcantly different from control at p < 0.05. (Statistical analysis was not performed on results from individual pups
because the litter rather than the pup is the experimental unit.)
Table 5. Effects of in utero and lactational DEHP exposure on indices of puberty in female rats.
Maternal DEHP dose (mg/kg/day)
Index 0 375 750 1,500
Age at vaginal opening (days) 31.1 ± 0.9 29.7 ± 0.9 29.7 ± 1.2 27.2 ± 1.1
Body weight at vaginal opening (g) 94 ± 6 87 ± 6 86 ± 9 64 ± 9*
Age at ﬁrst estrus (days) 33.5 ± 0.3 33.1 ± 0.4 35.8 ± 2.0 34.4 ± 0.7
Body weight at ﬁrst estrus (g) 108 ± 4 105 ± 2 116 ± 11 98 ± 2
Dams were orally dosed with DEHP or vehicle from GD 3 through PND 21. Values are means ± SE of the litter means. Age
and body weight at vaginal opening were determined for all females per litter, while age and body weight at ﬁrst estrus
were determined for 2 females per litter. There were eight litters with females in the control and low-dose groups, seven
at the middle dose, and ﬁve at the high dose.
*Signiﬁcantly different from control at p < 0.05.the lack of ejaculatory behavior in more than
half the DEHP-exposed rats cannot be attrib-
uted to inadequate circulating testosterone.
It is highly unlikely that undescended
testes could account for the lack of ejaculatory
behavior, inasmuch as testicular steroidogene-
sis is independent of testicular position.
Furthermore, only two of the nine DEHP-
exposed rats that failed to ejaculate had an
undescended testis (one each), and one
DEHP-exposed rat with an undescended
testis had completely normal sexual behaviors.
Incomplete preputial separation could
potentially prevent ejaculation but cannot
account for failure of ﬁve of the 16 DEHP-
exposed rats to mount a single time.
Furthermore, six of the nine DEHP-exposed
rats that did not ejaculate had full preputial
separation, and one DEHP-exposed rat that
ejaculated had incomplete preputial separa-
tion. The glans penis was abnormally small
(< 92% of control) in six of nine DEHP-
exposed rats that did not ejaculate but also
in two of the seven that did (an organ was
considered abnormally small if it weighed
less than the control mean weight – 2 SDs
from the control mean). The reduction in
glans penis weight in DEHP-exposed rats
that did not ejaculate averaged only 13%.
These observations suggest that failure to
ejaculate was not caused by smaller penis
size. Moreover, a small penis cannot account
for the failure of rats to mount. Finally, no
DEHP-exposed male that failed to ejaculate
had any detectable penile abnormality (other
than incomplete preputial separation).
In short, we saw no evidence that abnor-
mal sexual behaviors in DEHP-exposed rats
were caused by effects on androgen concen-
trations in adulthood or by abnormal male
reproductive organs. Instead, the most likely
explanation is that in utero and lactational
DEHP exposure causes incomplete sexual
differentiation of the CNS. Further research
is needed to conﬁrm or reject this hypothesis.
Comparison with standard teratogenic-
ity testing. Although reductions in anogeni-
tal distance, epididymal malformations, and
accessory sex organ agenesis can be detected
before birth, no such effects were reported in
any of the 14 published studies on effects of
DEHP on fetal morphology (3). Classic ter-
atogenicity testing clearly plays an important
role in the assessment of potential toxic
responses, but studies such as those con-
ducted in our laboratory or by Gray et al.
(24) demonstrate that teratogenicity testing
is not routinely being conducted in a way
that permits detection of some major male
reproductive system abnormalities.
Sensitivity of male rats to in utero and
lactational DEHP exposure. Effects of in
utero and lactational DEHP exposure on
male reproductive system development were
dose related, and the lowest observed adverse
effect level was the lowest dose tested (375
mg/kg/day). Two effects were statistically
signiﬁcant at this dose: reductions in anterior
prostate weight and permanent nipple
retention. Effects that were not statistically
significant within the constraints of this
experiment (n ≤ 8) but which are so unusual
among control rats as to be considered bio-
logically significant at 375 mg/kg/day are
testis nondescent, permanently incomplete
preputial separation, and accessory sex organ
agenesis. Although an occasional control
male rat is sexually inactive, the total lack of
sexual activity by three of seven males sug-
gests that 375 mg DEHP/kg/day can also
demasculinize sexual behaviors.
Because no single abnormality was seen
in all affected males, we evaluated sensitivity
to DEHP in two additional ways. We tabu-
lated the incidence of major male reproduc-
tive system defects per litter using data from
all necropsies. We found no major abnor-
malities (deﬁned in the legend to Figure 4)
in any of eight control litters, but DEHP
caused statistically significant incidences of
major reproductive toxicity at each dose
tested (Figure 4A). In several cases the same
litter had males that appeared normal and
others that were severely affected. The cause
of this variability is unknown. Because this
analysis gave the same weight to litters in
which a single male had a single abnormality
as it did to litters in which each male had
multiple abnormalities, we also evaluated
sensitivity to account for differences in the
extent to which litters were abnormal.
Criteria for this analysis, which were some-
what less stringent than those used above,
are stated in the legend to Figure 4. Figure
4B shows that litters exposed to 0, 375, 750,
and 1,500 mg DEHP/kg averaged 1, 18, 52,
and 73% of the possible abnormalities,
respectively, and that the effect of DEHP on
the extent to which abnormalities were pre-
sent was signiﬁcant at each dose.
Nipple retention was the abnormality
most frequently seen in adulthood, and the
percentage of males with areolas on PND 14
was even higher. Yet most DEHP-exposed
males that had no detectable nipples in
adulthood had other abnormalities, as did
most DEHP-exposed males without areolas
at PND 14. These results demonstrate that
multiple male reproductive system end
points must be evaluated to detect all rats
with abnormalities caused by in utero and
lactational exposure to DEHP and, presum-
ably, other antiandrogens.
Effects of DEHP resemble but are differ-
ent from those of other phthalate esters.
Although numerous phthalate esters are in
wide use, information about their possible
effects on sexual development is available for
only a few. Single-dose exposure to di(2-
methoxyethyl) phthalate (700 mg/kg) caused
testicular atrophy and displacement in fetuses
(37), but no other reproductive system
abnormalities were noted. The only effect of
continuous dietary exposure to 5.0% di(n-
octyl) phthalate was a reduction in seminal
vesicle weight (38), and continuous exposure
to di(isononyl) phthalate had no effect on the
male reproductive system at 500 mg/kg/day
(39). Butyl benzyl phthalate has been studied
only at doses far smaller than we used; effects
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Figure 4. Effects of in utero and lactational DEHP exposure on (A) the incidence of reproductive deﬁcits per
litter and (B) the relative number of abnormalities per rat. (A) DEHP was considered to have caused major
reproductive toxicity in a litter if any male from that litter had one or more of the following: missing or
severely malformed sex organs, one testis or epididymis that weighed < 75% of the other, incomplete
preputial separation, or an undescended testis in adulthood. (B) The index of abnormalities is a score
based on how many sex organs were missing, obviously pathological, or abnormally small and, when
applicable, whether rats had nipples and/or undescended testes in adulthood, whether preputial separa-
tion was permanently incomplete, and whether they failed to ejaculate during sex-behavior testing. Organs
were considered to be abnormally small if they weighed less than the mean control weight – 2 SDs from
the control mean. Scores were calculated as the percentage of end points (7–13 per rat) in which each
male was found to be abnormal. Litter means were then calculated. Each point in (B) represents the mean
± SE. The number of replicates (litters) was 8 at 0, 375, and 750 mg/kg/day, and 5 at 1,500 mg/kg/ day. 
*Signiﬁcantly different from control at p < 0.05.
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were conﬁned to the testis and could not be
reproduced consistently (40–42). In contrast,
development of the male reproductive system
in rats is profoundly affected by continuous
multigenerational (43), in utero (44), or in
utero and lactational exposure to di(n-butyl)
phthalate (7,45,46). Effects appear to be
caused by an antiandrogenic mechanism that
does not involve direct interaction with
androgen receptors (45). Our experiments
were similar to those of Mylchreest et al. (7)
in most ways, and many similarities between
effects of di(n-butyl) phthalate and DEHP
were found. 
Yet there are several striking differences.
Di(n-butyl) phthalate caused high incidences
of epididymal and seminal vesicle agenesis,
whereas DEHP caused low incidences of
both, and when DEHP caused epididymal
agenesis, it was partial rather than complete.
Di(n-butyl) phthalate caused ventral prostate
agenesis in only one rat and no anterior
prostate agenesis, whereas DEHP caused a
moderate incidence of ventral prostate agen-
esis and a high incidence of anterior prostate
agenesis. And DEHP prevented completion
of preputial separation in several rats,
whereas di(n-butyl) phthalate did not. The
fact that there are substantial differences in
the nature of the effects of continuous expo-
sure to DEHP, di(n-butyl) phthalate, di(n-
octyl) phthalate, and di(isononyl) phthalate
suggests that these chemicals affect male
reproductive system development by some-
what different mechanisms. Additional
research is needed to determine which mech-
anisms are common to all phthalate esters
and which are specific to individual mem-
bers of this family.
We are unaware of any previous report
in which the predominant effect of any
chemical was agenesis of the anterior
prostate. Although many effects of DEHP
can potentially be attributed to possible
reductions in perinatal androgen concentra-
tions and/or systemic impairment in respon-
siveness to androgens, the strikingly high
incidence of anterior prostate agenesis sug-
gests that DEHP affects this organ by one or
more mechanisms unique to the anterior
prostate and/or portions of the urogenital
sinus and Wolfﬁan ducts that give rise to it.
The fact that DEHP exposure was continu-
ous from GD 3 through PND 21 indicates
that anterior prostate agenesis is not caused
by some unique aspect of the timing of
exposure.
The observation that preputial separa-
tion was never completed in many DEHP-
exposed rats is also highly unusual. Except
for Wolf et al.’s study of vinclozolin (47), we
are unaware of any report that preweaning
exposure to any chemical can cause a perma-
nent blockade of preputial separation.
Implications for human health. Most
previous experiments on effects of DEHP
on the male reproductive system gave juve-
nile or adult animals 1,000–2,000 mg
DEHP/kg/day. Results of our experiments
demonstrate that the male reproductive sys-
tem is substantially more sensitive to DEHP
when exposure occurs early in development.
In addition, in utero and lactational DEHP
exposure caused effects (e.g., prostate agene-
sis) it was inherently incapable of causing if
exposure had been delayed until after wean-
ing. Nevertheless, these results do not
demonstrate that reproductive system devel-
opment in the average human male is at risk
from DEHP exposure.
Acceptable human exposures to chemicals
are typically calculated by reducing no-
observed adverse effect levels (NOAELs) from
animal experiments 100-fold to account for
possible 10-fold differences in inter- and
intraspecies variability. Because we did not
determine a NOAEL, an additional 10-fold
uncertainty factor would typically be used.
When these safety factors are considered, the
reference dose (acceptable daily intake) for
male reproductive system effects in humans
would be 375 µg DEHP/kg/day. This is still
far higher that typical human exposure to
DEHP, which is estimated to be 4–30 µ
g/kg/day (5). Results of our experiments sug-
gest, therefore, that sexually dimorphic devel-
opment in most humans is unlikely to be
affected by DEHP alone (although DEHP
could still affect human development in com-
bination with chemicals that act by similar
mechanisms). Even adults who receive fre-
quent transfusions from DEHP-plasticized
blood bags receive only an additional 36
µg/kg/day (5). However, long-term dialysis
patients are reported to average 457
µg/kg/day (5), and newborn infants undergo-
ing exchange transfusion receive 1,700–4,200
µg/kg (5,48). Consequently, DEHP exposure
by these patients is greater than the acceptable
daily intake for abnormal sexual development
suggested by our results.
Arcadi et al. (23) examined effects of
DEHP at substantially lower doses than we
used. Rats that consumed 32.5 and 325 µL
DEHP per liter of drinking water during
pregnancy and lactation (roughly 3–5 and
30–50 mg/kg/day, respectively) gave birth to
pups with lower testis wights and altered tes-
ticular morphology. Their results imply that
the acceptable daily intake for DEHP is only
3 µg/kg/day, which is at the low end of the
range of typical human exposure.
Most recently, Gray and colleagues
reported that maternal DEHP treatment can
greatly reduce testosterone production in
fetal and neonatal rats, whereas neither
DEHP nor a major metabolite bound to
androgen receptors (49). Reductions in
testosterone synthesis undoubtedly con-
tribute to abnormal male reproductive sys-
tem development, but this mechanism alone
cannot account fully for the pattern of
effects we observed.
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